222 related articles for article (PubMed ID: 28052020)
21. The CEA-/lo colorectal cancer cell population harbors cancer stem cells and metastatic cells.
Yan C; Hu Y; Zhang B; Mu L; Huang K; Zhao H; Ma C; Li X; Tao D; Gong J; Qin J
Oncotarget; 2016 Dec; 7(49):80700-80715. PubMed ID: 27813496
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
[TBL] [Abstract][Full Text] [Related]
24. The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells.
Manco M; Ala U; Cantarella D; Tolosano E; Medico E; Altruda F; Fagoonee S
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439247
[TBL] [Abstract][Full Text] [Related]
25. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
Zhong G; Li H; Shan T; Zhang N
Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
[TBL] [Abstract][Full Text] [Related]
26. The ESRP1-GPR137 axis contributes to intestinal pathogenesis.
Mager LF; Koelzer VH; Stuber R; Thoo L; Keller I; Koeck I; Langenegger M; Simillion C; Pfister SP; Faderl M; Genitsch V; Tcymbarevich I; Juillerat P; Li X; Xia Y; Karamitopoulou E; Lyck R; Zlobec I; Hapfelmeier S; Bruggmann R; McCoy KD; Macpherson AJ; Müller C; Beutler B; Krebs P
Elife; 2017 Oct; 6():. PubMed ID: 28975893
[TBL] [Abstract][Full Text] [Related]
27. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
28. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
29. Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
Jung Y; Jun Y; Lee HY; Kim S; Jung Y; Keum J; Lee YS; Cho YB; Lee S; Kim J
Oncotarget; 2015 Sep; 6(28):25368-80. PubMed ID: 26196590
[TBL] [Abstract][Full Text] [Related]
30. The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.
Liang YC; Lin WC; Lin YJ; Lin JC
Oncotarget; 2015 Nov; 6(35):38046-60. PubMed ID: 26506517
[TBL] [Abstract][Full Text] [Related]
31. High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer.
Luo Y; Ye GY; Qin SL; Mu YF; Zhang L; Qi Y; Qiu YE; Yu MH; Zhong M
Int J Biochem Cell Biol; 2016 Jun; 75():53-62. PubMed ID: 27046094
[TBL] [Abstract][Full Text] [Related]
32. Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer.
Matsuda Y; Ishiwata T; Yamahatsu K; Kawahara K; Hagio M; Peng WX; Yamamoto T; Nakazawa N; Seya T; Ohaki Y; Naito Z
Cancer Lett; 2011 Oct; 309(2):209-19. PubMed ID: 21745712
[TBL] [Abstract][Full Text] [Related]
33. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
[TBL] [Abstract][Full Text] [Related]
34. P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth.
He H; Huynh N; Liu KH; Malcontenti-Wilson C; Zhu J; Christophi C; Shulkes A; Baldwin GS
Cancer Lett; 2012 Apr; 317(1):65-71. PubMed ID: 22100495
[TBL] [Abstract][Full Text] [Related]
35. PTRF suppresses the progression of colorectal cancers.
Wang F; Zheng Y; Orange M; Yang C; Yang B; Liu J; Tan T; Ma X; Chen T; Yin X; Tang X; Zhu H
Oncotarget; 2017 Jul; 8(30):48650-48659. PubMed ID: 27203393
[TBL] [Abstract][Full Text] [Related]
36. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
37. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.
Bae JA; Yoon S; Park SY; Lee JH; Hwang JE; Kim H; Seo YW; Cha YJ; Hong SP; Kim H; Chung IJ; Kim KK
Clin Cancer Res; 2014 Aug; 20(15):4115-28. PubMed ID: 24893630
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
39. Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.
Zhao Y; Li M; Wu W; Miao W; Liu H
Front Immunol; 2023; 14():1161273. PubMed ID: 37090731
[TBL] [Abstract][Full Text] [Related]
40. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
